Elsevier

Vaccine

Volume 14, Issue 4, March 1996, Pages 329-336
Vaccine

Paper
Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers

https://doi.org/10.1016/0264-410X(95)00167-YGet rights and content

Abstract

A live-attenuated dengue 2 vaccine (strain 16681 PDK 53) developed at Mahidol University, Thailand was evaluated for safety and immunogenicity by administering 104 p.f.u. subcutaneously to ten flavivirus non-immune American volunteers. The vaccine was safe; there were no serious adverse reactions. Eight recipients experienced no or mild side effects. One recipient reported headaches on 7 separate days. One volunteer, who had a fracture of the humerus 1 day after vaccination requiring surgical repair, experienced generalized malaise with fever (maximum temperature=38.9°C), headache, eye pain and myalgia lasting less than 24 h. The vaccine was highly immunogenic; all recipients developed neutralizing antibody that persisted for two years.

References (14)

  • N. Bhamarapravati et al.

    Study of bivalent dengue vaccine in volunteers

    Lancet

    (1989)
  • J.R. Bravo et al.

    Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHFDSS)

    Trans. R. Soc. Trop. Med. Hyg.

    (1987)
  • W.E. Brandt

    From the World Health Organization. Development of dengue and Japanese encephalitis vaccines

    J. Infect. Dis.

    (1990)
  • D.J. Gubler

    Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up

  • N. Bhamarapravati et al.

    Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers

    Bull. WHO

    (1987)
  • B.L. Innis et al.

    An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate

    Am. J. Trop. Med. Hyg.

    (1989)
  • D.H. Clarke et al.

    Techniques for hemagglutination and hemagglutination inhibition with arthropod-borne viruses

    Am. J. Trop. Med. Hyg.

    (1958)
There are more references available in the full text version of this article.

Cited by (0)

View full text